|
New challenges in the diagnosis of Alzheimer’s disease: the
significance of biological markers
Raffaele Antonelli Incalzi
Apolipoprotein E epsilon allele and risk of late-onset
Alzheimer's disease
Travis Dunkley
Non-apoE genetics in Alzheimer's disease
Bruno Dallapiccola, Alberto Pilotto
Markers of oxidative damage in Alzheimer's disease
Patrizia Mecocci
The proteomics in the evaluation of cerebrospinal fluid
biomarkers of Alzheimer's disease
Kelvin H Lee
Altered autophagical function in Alzheimer’s disease
Wei-dong Le
Lymphocyte and cerebral β-adrenergic receptor signaling
abnormalities in patients with Alzheimer’s disease:
relationships with cognitive impairment
Dario Leosco
MAP Kinase signaling cascade dysfunction specific to Alzheimer’s
disease in fibroblasts
Wei-Qin Zhao
Cardiovascular and metabolic risk factors: a possible link with
Alzheimer’s disease
Franco Rengo
Brain imaging and cognitive function in Alzheimer’s disease
Giovanni B Frisoni
Cerebrospinal fluid levels of biomarkers in Alzheimer’s patients
before and after treatment with different AChE inhibitors
Kaj Blennow, Ulf Andreasson, and Henrik Zettelberg |
